Date: 24 Nov 2012
Endothelial nitric oxide synthase polymorphism G298T in association with oxidative DNA damage in coronary atherosclerosis
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Heart disease has become a major public health problem in many developing countries and is the most important cause of mortality in India. There is an epidemiological transition of this degenerative disease with increase in prevalence of cardiovascular risk factors (Sukanta et al.2009). Coronary artery disease (CAD) is the most common form of heart disease (Sukanta et al.2009).
There is evidence that physiological and functional alterations in endothelial cells may play a pivotal role in progression of atherosclerotic lesions (De 2000). Nitric oxide (NO) is an important free radical mostly produced by endothelial cells. It plays an important role in vascular relaxation, and displays vasoprotective effects by scavenging superoxide radicals (Loscalzo and Welch 1995) and suppressing platelet aggregation, leucocyte adhesion and smooth muscle cell proliferation and signalling (Radomski et al.1887).
Generally NO is synthesized by endothelial nitric oxide synthase (eNOS) in vasculat...
[Kumar R. G., Spurthi M. K., Kumar K. G., Sahu S. K. and Rani S. H. 2012 Endothelial nitric oxide synthase polymorphism G298T in association with oxidative DNA damage in coronary atherosclerosis. J. Genet. 91, xx–xx]
Ahuja Y. R. and Saran R. 1999 Alkaline single cell gel electrophoresis assay. I. Protocol. J. Cytol. Genet. 34, 57–62.
De C. R. 2000 Endothelial dysfunctions: common denominators in vascular disease. Curr. Opin. Lipidol. 11, 9–23.CrossRef
Isabella D. D., Ranieri R., Roberto C., Daniela G. and Aldo M. 2006 Biomarkers of oxidative damage in human disease. Clin. Chem. 52, 601–623.CrossRef
Kathy K. G. and Garret A. F. 2003 Part I: basic mechanisms and in vivo monitoring of ROS. Circulation 108, 1912–1916.CrossRef
Martin R. B. 2001 Reactive oxygen species and death oxidative DNA damage in atherosclerosis. Circ. Res. 88, 648–650.CrossRef
Nishevitha N. S., Angeline T. and Nirmala J. 2009 Endothelial nitric oxide synthase (eNOS) Glu298Asp polymorphism (G894T) among south Indians. Indian J. Med. Res. 129, 68–71.PubMed
Radomski M. W., Palmer R. M. and Moncada S. 1887 Endogenous nitric oxide inhibitshuman platelet adhesion to vascular endothelium. Lancet 2, 1057–1058.
Shimasaki Y., Yasue H., Yoshimura M., Nakayama M., Kugiyama K., Ogawa H. et al. 1998 endothelial nitric oxide synthase: the influence of cofactors. Proc. Natl. Acad. Sci. USA 95, 9220–9225.CrossRef
Sukanta M., Joyti B. S., Sankar C. M., Rudra N. B., Manashi C. and Partha P. P. 2009 Prevalence of ischemic heart disease among urban population of Siliguri, West Bengal. Indian J. Community Med. 34, 19–23.CrossRef
- Endothelial nitric oxide synthase polymorphism G298T in association with oxidative DNA damage in coronary atherosclerosis
Journal of Genetics
Volume 91, Issue 3 , pp 349-352
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- coronary artery disease
- endothelial nitric oxide synthase
- myocardial infarction
- reactive oxygen species